Abstract:Objectives. To evaluate the normal distribution of serum prostate-specific antigen (PSA) levels in healthy Chinese men, because, until recently, studies conducted to establish normal serum PSA values have not involved a Chinese population. Methods. Between September 1999 and December 2001, 1096 healthy Chinese men aged 23 to 85 years, who had undergone a routine health examination, were recruited to this study. All underwent detailed clinical examinations, including serum PSA determination and digital rectal examination. All men with abnormal digital rectal examination findings and/or an abnormal serum PSA level (greater than 4.0 ng/mL) underwent transrectal ultrasound-guided sextant biopsy. Results. The median serum PSA concentration was 0.50 ng/mL (95th percentile 1.20) for men 23 to 29 years old (n = 77); 0.55 ng/mL (95th percentile 1.21) for men 30 to 39 years old (n = 189); 0.54 ng/mL (95th percentile 1.23) for men 40 to 49 years old (n = 233); 0.82 ng/mL (95th percentile 2.35) for men 50 to 59 years old (n = 177); 0.93 ng/mL (95th percentile 3.20) for men 60 to 69 years old (n = 265); and 1.17 ng/mL (95th percentile 3.39) for men 70 years old or older (n = 155). The serum PSA concentration correlated with age (P < 0.001), with an increase of approximately 1.1% annually. No change occurred in the median serum PSA value and 95th percentile in men younger than 50 years old; a gradual increase was observed in men older than 50 years. In those 50 years old or older, the median and 95th percentile serum PSA values for Chinese men were significantly lower than those for other races and even for other Asian men. Conclusions. These findings further confirm that the serum PSA level correlates with age. Moreover, the distribution and cutoff value of the serum PSA level differs along ethnic lines. In addition, our findings raise the question of whether lowering the PSA cutoff may enhance the detection of cancer in Chinese men who have the lowest prostate cancer rate. (C) 2004 Elsevier Inc.

Body Mass Index Correlates with the Level of Serum Prostate-Specific Antigen in Men in Fangcheng Area of Guangxi

The relationship between body mass index and the level of serum prostate-specific antigen in 15 830 adult males in Xi'an

[Relationship Between Serum Prostate-Specific Antigen Levels and Body Mass Index in Beijing Men over 50 Years of Age].

Study on the relationship between BMI and serum prostate specific antigen in middle and old aged males

Correlation Between Body Mass Index (BMI) and the Gleason Score of Prostate Biopsies in Chinese Population

Impact of body mass index on detection and Gleason score of prostate cancer at biopsy

Age-Specific Cutoff Value for the Application of Percent Free Prostate-Specific Antigen (PSA) in Chinese Men with Serum PSA Levels of 4.0-10.0 Ng/ml.

Higher Body Mass Index Increases the Risk for Biopsy-Mediated Detection of Prostate Cancer in Chinese Men.

Effect of Body mass index on the performance characteristics of PSA-related markers to detect prostate cancer

Distribution of Serum Prostate-Specific Antigen in Chinese Healthy Men: a Population-Based Study.

Association of Serum Uric Acid with Body Mass Index: A Cross-Sectional Study from Jiangsu Province, China.

Relationship of body mass index and blood lipid level with cancer detection on prostate biopsy

Ethnic differences in distribution of serum prostate-specific antigen: a study in a healthy Chinese male population.

The Association Between Body Mass Index and Testosterone Deficiency in Aging Chinese Men with Benign Prostatic Hyperplasia: Results from a Cross-Sectional Study

The relationship between body mass index and serum levels of reproductive hormones in middle-aged and elderly Chinese men

Body Mass Index and Mortality: A 10-Year Prospective Study in China

Relationship Between Serum Sex Hormones Levels and Degree of Benign Prostate Hyperplasia in Chinese Aging Men

Body mass index and risk of BPH: a meta-analysis

Corelation of Body Mass Index with Cancer Detection on Prostate Biopsy and Higher Gleason Score

Effect of boby mass index on positive rate of prostate cancer and Gleason score in the patients undergoing transrectal prostate biopsy

Body mass weighted PSA levels, new markers to predict locally advanced prostate cancer after prostatectomy